Search research articles
Contact Us
Filters
Showing results (91-100 of 160) with videos related to
Page
of 16
Sort By:
Leukemia
|
September 27, 2003
Allogeneic stem cell transplantation for advanced acute promyelocytic leukemia: results in patients treated in second molecular remission or with molecularly persistent disease
F Lo-Coco, A Romano, A Mengarelli, et al.
Bone Marrow Transplantation
|
March 7, 2003
Hepatitis reactivation and liver failure in haemopoietic stem cell transplants for hepatitis B virus (HBV)/hepatitis C virus (HCV) positive recipients: a retrospective study by the Italian group for blood and marrow transplantation
A Locasciulli, B Bruno, E P Alessandrino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 19, 2002
Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia
O Ringdén, M Labopin, A Bacigalupo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1991
Interferon therapy for Ph1-positive chronic myelogenous leukaemia patients relapsing after T-cell depleted allogeneic bone marrow transplantation
W Arcese, F R Mauro, M Screnci, et al.
Haematologica
|
March 21, 1998
A single high dose of idarubicin combined with high-dose ARA-C (MSKCC ALL-3 protocol) in adult and pediatric patients with acute lymphoblastic leukemia. Experience at the University "La Sapienza" of Rome
A M Testi, M L Moleti, F Giona, et al.
Haematologica
|
December 24, 1997
A single high dose of idarubicin combined with high-dose ABA-C (MSKCC ALL-3 protocol) in adult and pediatric patients with acute lymphoblastic leukemia. Experience at the University La Sapienza of Rome
A M Testi, M L Moleti, F Giona, et al.
Leukemia
|
April 1, 1993
Mitoxantrone, etoposide and intermediate-dose Ara-C (MEC): an effective regimen for poor risk acute myeloid leukemia
A Spadea, M C Petti, P Fazi, et al.
European Journal of Haematology. Supplementum
|
January 1, 1990
Alpha-2b-interferon as single therapy for patients with chronic myeloid leukemia relapsing after T-cell depleted allogeneic bone marrow transplantation
W Arcese, F R Mauro, M Screnci, et al.
The New England Journal of Medicine
|
August 7, 1997
Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group
E Gluckman, V Rocha, A Boyer-Chammard, et al.
British Journal of Haematology
|
August 12, 1999
Flt3LP3nduces the ex-vivo amplification of umbilical cord blood committed progenitors and early stem cells in short-term cultures
L De Felice, T Di Pucchio, M G Mascolo, et al.
Page
of 16
Search research articles
Search
Showing results (91-100 of 160) with videos related to
Sort By:
Page
of 16
Leukemia
|
September 27, 2003
Allogeneic stem cell transplantation for advanced acute promyelocytic leukemia: results in patients treated in second molecular remission or with molecularly persistent disease
F Lo-Coco, A Romano, A Mengarelli, et al.
Bone Marrow Transplantation
|
March 7, 2003
Hepatitis reactivation and liver failure in haemopoietic stem cell transplants for hepatitis B virus (HBV)/hepatitis C virus (HCV) positive recipients: a retrospective study by the Italian group for blood and marrow transplantation
A Locasciulli, B Bruno, E P Alessandrino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 19, 2002
Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia
O Ringdén, M Labopin, A Bacigalupo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1991
Interferon therapy for Ph1-positive chronic myelogenous leukaemia patients relapsing after T-cell depleted allogeneic bone marrow transplantation
W Arcese, F R Mauro, M Screnci, et al.
Haematologica
|
March 21, 1998
A single high dose of idarubicin combined with high-dose ARA-C (MSKCC ALL-3 protocol) in adult and pediatric patients with acute lymphoblastic leukemia. Experience at the University "La Sapienza" of Rome
A M Testi, M L Moleti, F Giona, et al.
Haematologica
|
December 24, 1997
A single high dose of idarubicin combined with high-dose ABA-C (MSKCC ALL-3 protocol) in adult and pediatric patients with acute lymphoblastic leukemia. Experience at the University La Sapienza of Rome
A M Testi, M L Moleti, F Giona, et al.
Leukemia
|
April 1, 1993
Mitoxantrone, etoposide and intermediate-dose Ara-C (MEC): an effective regimen for poor risk acute myeloid leukemia
A Spadea, M C Petti, P Fazi, et al.
European Journal of Haematology. Supplementum
|
January 1, 1990
Alpha-2b-interferon as single therapy for patients with chronic myeloid leukemia relapsing after T-cell depleted allogeneic bone marrow transplantation
W Arcese, F R Mauro, M Screnci, et al.
The New England Journal of Medicine
|
August 7, 1997
Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group
E Gluckman, V Rocha, A Boyer-Chammard, et al.
British Journal of Haematology
|
August 12, 1999
Flt3LP3nduces the ex-vivo amplification of umbilical cord blood committed progenitors and early stem cells in short-term cultures
L De Felice, T Di Pucchio, M G Mascolo, et al.
Page
of 16